"Independent and government data continue to show prescription medicines represent a small and decreasing share of growth in overall health care costs in the United States," said Rick Smith, senior vice president of the Pharmaceutical Research and Manufacturers of America, in response to an AARP report that said prices of brand-name drugs commonly prescribed under Medicare rose 8.3% last year.

Full Story:
Hill, The

Related Summaries